Jack et al. developed a new therapeutic strategy that combines EGF with an anthrax toxin proposed for BCa, and the toxin is specifically taken up by cancer cells and induces rapid apoptosis after intravesical application, regardless of whether the cancer cells express Her2. This evidence concerns the gene ERBB2 and cancer.